BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

SpaceIT Hydrogel System for Perirectal Spacing

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Device: SpaceIT Hydrogel System
Device: Commercially available Boston Scientific Spacer

First Posted Date: 2024-06-11

Last Posted Date: 2024-12-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 230

Registration Number: NCT06451614

Locations: 🇺🇸
Springfield Clinic, LLC, Springfield, Illinois, United States
🇺🇸
Baptist Hospital of Miami, Miami, Florida, United States

ADVENT Post-Approval Study

Recruiting

Conditions: Paroxysmal Atrial Fibrillation

First Posted Date: 2024-05-29

Last Posted Date: 2024-12-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 220

Registration Number: NCT06431815

Locations: 🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸
Scottsdale Healthcare - Shea, Scottsdale, Arizona, United States
🇺🇸
Alta Bates Summit Medical Center, Oakland, California, United States

and more 31 locations

First In Human Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device

Not Applicable

Active, not recruiting

Conditions: Cancer
Prostate

Interventions: Device: TheraSphere PCa

First Posted Date: 2024-01-05

Last Posted Date: 2024-11-27

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 36

Registration Number: NCT06192758

Locations: 🇺🇸
University of Miami (Sylvester Comprehensive Cancer Center), Miami, Florida, United States
🇺🇸
Ronald Reagan UCLA Medical Center (UCLA Health, Los Angeles), Los Angeles, California, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States

and more 2 locations

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE

Not Applicable

Not yet recruiting

Conditions: Gastric Outlet Obstruction

Interventions: Device: AXIOS(TM) Stent and Electrocautery Enhanced Delivery System

First Posted Date: 2023-12-18

Last Posted Date: 2024-12-20

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 67

Registration Number: NCT06174805

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
New York Presbyterian/ Weill Cornell Medical Center, New York, New York, United States

and more 6 locations

Feasibility Study on the FARAVIEW Technology

Not Applicable

Active, not recruiting

Conditions: Paroxysmal Atrial Fibrillation
Persistent Atrial Fibrillation
Atrial Fibrillation

Interventions: Device: Ablation Treatment

First Posted Date: 2023-12-18

Last Posted Date: 2024-12-20

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 60

Registration Number: NCT06175234

Locations: 🇨🇿
Na Homolce Hospital, Prague, Czechia
🇮🇪
Mater Private Hospital, Dublin, Ireland
🇪🇸
Clínica Universidad de Navarra, Pamplona, Navarra, Spain

Obsidio™ Conformable Embolic Registry

Recruiting

Conditions: Hypervascular Tumors
Hemorrhage
Bleeding

Interventions: Device: Obsidio™ Conformable Embolic

First Posted Date: 2023-12-14

Last Posted Date: 2024-11-27

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 125

Registration Number: NCT06170619

Locations: 🇺🇸
University of Texas Houston Health Science Center, Houston, Texas, United States
🇺🇸
Mayo Clinic Hospital, Phoenix, Arizona, United States
🇺🇸
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States

and more 17 locations

POLARx Post Approval Study (POLARx PAS)

Not Applicable

Recruiting

Conditions: Paroxysmal Atrial Fibrillation

Interventions: Device: Boston Scientific Cardiac Cryoablation System

First Posted Date: 2023-12-14

Last Posted Date: 2024-11-15

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 200

Registration Number: NCT06170606

Locations: 🇺🇸
Aurora Health, Grafton, Wisconsin, United States
🇺🇸
Banner University Medical Center Phoenix, Phoenix, Arizona, United States
🇺🇸
Pima Heart & Vascular Clinical Research, Tucson, Arizona, United States

and more 3 locations

VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)

Not Applicable

Active, not recruiting

Conditions: High-risk Percutaneous Coronary Intervention
Heart Disease, Coronary

Interventions: Device: VITALYST System

First Posted Date: 2023-11-15

Last Posted Date: 2024-12-20

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 15

Registration Number: NCT06132568

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Columbia University Medical Center/New York Presbyterian Hospital, New York, New York, United States
🇸🇪
Skane University Hospital, Lund, Sweden

and more 2 locations

Pulsed Field Ablation (PFA) Vs Anti-Arrhythmic Drug (AAD) Therapy As a First Line Treatment for Persistent Atrial Fibrillation

Not Applicable

Recruiting

Conditions: Persistent Atrial Fibrillation

Interventions: Device: FARAPULSE™ Pulsed Field Ablation (PFA) System

First Posted Date: 2023-10-23

Last Posted Date: 2024-12-20

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 520

Registration Number: NCT06096337

Locations: 🇧🇪
St. Jan, Brugge, Belgium
🇺🇸
Scripps Memorial Hosptial, La Jolla, California, United States
🇺🇸
Stanford University Medical Center, Palo Alto, California, United States

and more 63 locations

SpyGlass Surgical Study

Active, not recruiting

Conditions: Pancreatic Diseases
Bile Duct Diseases
Hepatic Disease

Interventions: Device: SpyGlass Discover Digital System or SpyGlass DS Direct Visualization System

First Posted Date: 2023-04-21

Last Posted Date: 2024-12-20

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 34

Registration Number: NCT05822635

Locations: 🇺🇸
Indiana University Health, Indianapolis, Indiana, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇨🇳
Lanzhou University No. 1 Hospital, Lanzhou, Gansu, China

and more 2 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy